NCT01265446View on ClinicalTrials.gov

Efficacy and Safety of a Sore Throat Lozenge Containing Lidocaine and Cetylpyridinium Chloride in Patients With Sore Throat Due to a Common Cold.

PHASE3CompletedINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

December 31, 2010

Primary Completion Date

April 30, 2011

Study Completion Date

April 30, 2011

Conditions
Sore Throat Due to a Common Cold
Interventions
DRUG

Lidocaine 8mg + CPC 2mg

one single dose

DRUG

Lidocaine 1mg + CPC 2mg

one single dose

Trial Locations (1)

Unknown

Socratec, Erfurt

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY